KUTANÖZ MASTOSİTOZ TANISI ALMIŞ YENİDOĞAN BEBEKTE ANAFLAKSİ: OLGU SUNUMU VE LİTERATÜR TARAMA

Yıl 2017, Cilt: 15 Sayı: 3, 71 - 74, 01.12.2017

Nuriye Tarakçı Murat Konak Munise Daye Hüseyin Altunhan Rahmi Örs

Öz

Mastositoz deri ve/veya iç organlarda aşırı mast hücre birikimi ile karakterize
kutanöz ve sistemik olarak sınıflandırılan bir grup hastalıktır. Semptomlar mast
hücre mediatörlerinin aşırı salınımına ve onların lokal veya sistemik
etkilerine bağlıdır. Mastositozisli hastalarda semptomlar hafif olabileceği
gibi hayatı tehdit eden anaflaktik reaksiyonlara da neden olabilmektedir.
Anaflaktik krizler literatürde genellikle sistemik tutulum varlığında ve
erişkin ya da çocukluk dönemlerinde bildirilmiştir. Biz burada bir günlük iken
kutanöz mastositoz tanısı almış ve yenidoğan döneminde anaflaksi gelişen bir
hastayı  literatür eşliğinde sunduk.

Mastocytosis is carachterized by excessive mast cell accumulation in the skin and/or internal organs. Mastocytosis is divided into two groups; systemic and cutaneous. Symptoms depend on excessive cytokine release and their local and systemic affects. Symptoms may be mild or cause life-threatening anaphylactic reactions. In the literature anaphylactic reactions reported in systemic disease of adult and childhood mastocytosis. We here present an anaphylaxis in the newborn with a diagnosis of cutaneous mastocytosis.

Anahtar Kelimeler

kutanöz mastositoz, yenidoğan, anaflaksi

Kaynakça

• 1. Brockow K, Jofer C, Behrendt H, Ring J. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy. 2008 Feb; 63 (2): 226-32.
• 2. Brockow K. Urticaria pigmentosa. Immunol Allergy Clin N Am. 2004 May; 24 (2): 287-316.
• 3. Shaffer HC, Parsons DJ, Peden DB, Morrell D. Recurrent syncope and anaphylaxis as presentation of systemic mastocytosis in a pediatric patient: case report and literature review. J Am Acad Dermatol. 2006 May; 54 (5): 210-3.
• 4. Horan RF, Austen KF. Systemic mastocytosis: retrospective review of a decade’s clinical experience at the Brigham and Women’s Hospital. J Invest Dermatol. 1991 Mar; 96 (3): 5S–13S.
• 5. Travis WD, Li CY, Bergstralh EJ, Yam LT, Swee RG. Systemic mast cell disease. Analysis of 58 cases and literature review. Medicine (Baltimore). 1988 Nov; 67 (6): 345–68.
• 6. Roberts LJd. Recurrent syncope due to systemic mastocytosis (clinical conference). Hypertension. 1984 Mar-Apr; 6: 285–94.
• 7. Lee SS, Unglik GA, Mar AW. Anaphylactic shock in a patient with mastocytosis. Med J Aust. 2012 Nov 5; 197 (9): 520-1.
• 8. Soter NA. The skin in mastocytosis. J Invest Dermatol. 1991 Mar; 96 (3): 32S-38S.
• 9. Shome G, Nangia R, Baldwin J. Flushing and syncopal episode in a 47-year-old female. Ann Allergy Asthma Immunol. 2001 Feb; 86: 161-5.
• 10. Ludolph-Hauser D, Rueff F, Fries C,Schopf P, Przybilla B. Constitutively raised serum concentrations of mast-cell tryptase and severe anaphylactic reactions to Hymenoptera stings. Lancet. 2001 Feb; 357: 361–2.
• 11. Haeberli G, Bronnimann M, Hunziker T, Muller U. Elevated basal serum tryptase and hymenoptera venom allergy: relation to severity of sting reactions and to safety and efficacy of venom immunotherapy. Clin Exp Allergy. 2003 Sep; 33 (9): 1216–20.
• 12. Shiloh-Malawsky Y, Confino Y, Yosipovitz A, Nass D, Augarten A. Mastocytosis: The pediatric emergency physician’s perspective. Pediatr Emerg Care. 2003 Jun; 19 (3): 172-3.
• 13. Valent P, Horny HP, Escribano L, Longley BJ, Li CY, Schwartz LB et al. Diagnosic criteria and classification of mastocytosis: a consensus proposal. Leuk Res. 2000 Jul; 25 (7): 603-25.
• 14. Tosun A, Aral YZ, Apaydın Ş, Karaman G, Çetin ED. Ürtikerya pigmentosa ve nöbet birlikteliği: Bir vaka takdimi. Çocuk Sağlığı ve Hastalıkları Dergisi. 2008; 51: 158-61.